24 filings
8-K
IMGO
Imago BioSciences, Inc.
11 Jan 23
Completion of Acquisition or Disposition of Assets
9:00am
8-K
IMGO
Imago BioSciences, Inc.
12 Dec 22
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
12:04pm
8-K
IMGO
Imago BioSciences, Inc.
21 Nov 22
Form of Tender and Support Agreement
7:03am
8-K
IMGO
Imago BioSciences, Inc.
9 Nov 22
Imago BioSciences Reports Third Quarter 2022 Financial
4:12pm
8-K
IMGO
Imago BioSciences, Inc.
1 Sep 22
Departure of Directors or Certain Officers
4:03pm
8-K
7kl85nnj zcjnl041d8q
18 Aug 22
Other Events
5:29pm
8-K
csok3zcd
12 Aug 22
Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates
4:18pm
8-K
5soiyoiq vxa78d4et
13 Jun 22
Regulation FD Disclosure
6:07am
8-K
wpen78 tbo
10 Jun 22
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
6:05am
8-K
a6iczipq
6 Jun 22
Submission of Matters to a Vote of Security Holders
8:19am
8-K
ydn6 ora6529lrgk
12 May 22
Imago BioSciences Reports First Quarter 2022 Financial Results and Provides Recent Business Updates
4:28pm
8-K
3r0l4
12 May 22
Regulation FD Disclosure
10:39am
8-K
upqm30esbdcqv2fn7vyi
9 May 22
Regulation FD Disclosure
10:01am
8-K
osofa4obg30y3lb
3 May 22
Imago BioSciences Announces Completion of Enrollment in Phase 2 Clinical Study of Bomedemstat in Essential Thrombocythemia
8:31am
8-K
xdf7cqd3
24 Mar 22
Imago BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results
4:34pm
8-K
siow91ls
23 Mar 22
Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer
4:21pm
8-K
hlbhm f62txfxdgjd1v
12 Jan 22
Other Events
4:16pm
8-K
1mkv2hi vpj
13 Dec 21
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2021
8:32am
8-K
yladkhd
19 Nov 21
Imago BioSciences Appoints Laurie Keating to Board of Directors
4:15pm
8-K
7rw9 pxddod8
10 Nov 21
Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Business Updates
4:17pm